Hydroxyurea interferes with point-of-care creatinine testing in children with sickle cell anemia

Ruth Namazzi1, Robert O Opoka2, Charles Ssuuna3

  • 1Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda.

BMC Research Notes
|June 19, 2026
PubMed

Insights

Hydroxyurea interferes with i-STAT creatinine tests in children with sickle cell anemia (SCA), potentially misdiagnosing kidney function. This interference impacts clinical decisions for SCA patients on hydroxyurea therapy.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Clinical Diagnostics

Background:

  • Sickle cell anemia (SCA) affects children globally, requiring careful monitoring of kidney function.
  • Point-of-care testing offers rapid results but requires validation for specific patient populations and treatments.
  • Hydroxyurea is a common treatment for SCA, but its potential interference with diagnostic assays is a concern.

Purpose of the Study:

  • To assess the accuracy of the i-STAT device for creatinine measurement in Ugandan children with SCA.
  • To investigate the clinical significance of assay interference caused by hydroxyurea.

Main Methods:

  • Secondary analysis of a randomized clinical trial involving 248 Ugandan children with SCA.
  • Comparison of creatinine levels measured by i-STAT and a reference laboratory.
  • Correlation of i-STAT creatinine values with serum hydroxyurea concentrations.

Main Results:

  • i-STAT and reference lab creatinine values were comparable at baseline.
  • Children on hydroxyurea showed significantly higher i-STAT creatinine levels compared to reference lab values (p=0.006).
  • Hydroxyurea concentration explained 73% of the variability in i-STAT creatinine results.

Conclusions:

  • Hydroxyurea causes clinically significant interference with point-of-care creatinine testing using the i-STAT device.
  • This interference may lead to misclassification of kidney function in children with SCA receiving hydroxyurea.
  • Careful consideration of assay interference is crucial for appropriate clinical decision-making in this population.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...